MIRA INFORM REPORT

 

 

Report Date :

20.11.2013

 

IDENTIFICATION DETAILS

 

Name :

B.L.LIFE SCIENCES PRIVATE LIMITED

 

 

Formerly Known As :

BIOSENSORS INTERNATIONAL (INDIA) PRIVATE LIMITED

 

 

Registered Office :

A-245, Ohla Industrial Area, Phase-I, New Delhi - 110020

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

03.03.1999

 

 

Com. Reg. No.:

55-098641

 

 

Capital Investment / Paid-up Capital :

Rs. 114.113 Millions

 

 

CIN No.:

[Company Identification No.]

U33112DL1999PTC098641

 

 

PAN No.:

[Permanent Account No.]

AACCB2350B

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Medical Equipments.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (47)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 1137000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

The management has seen a better increase in its sales turnover as well as net profitability during 2013. The company possesses a healthy capital structure. The ratings also take into consideration the working capital intensive nature of the business and modest scale of operations.

 

However, trade relations are fair. Business is active. Payment terms are reported as usually correct.

 

In view of promoters extensive industry experience, the company can be considered for business dealings at usual trade terms and conditions.  

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

The current downturn provides an opportunity to push ahead with reforms to accelerate growth, says the latest India Development Update report released by the World Bank. The report says that the adverse effects of rupee depreciation are likely to be offset by the gains in the exports performance due to improved external competitiveness. Since May this year, the local currency has depreciated substantially and fell to a record level of Rs 68.85 to a dollar on August, 28.

 

A stagflation like situation appears to have arisen as inflation jumped to an eight month high of 6.46 % for the month of September. It is up from 6.10 % in August. Growth continues to be muted with factory output plunging to 0.6 % in August. Onion prices have risen nearly 300 % from last September. Vegetables cost nearly 90 % more than they did last year. Wake up to the economic contribution of slum dwellers. They contribute more than 7.5 % to the country’s gross domestic product, according to a recent study conducted in 50 top cities.

 

136000 estimated number of jobs created during the second quarter of the current financial year. 50000 estimated number of additional jobs in the field of corporate social responsibility in the coming years.

 

The International Finance Corporation expects to come out with its rupee linked bonds issue before the end of 2013 as a part of its plan to raise $ 1 billion. The Apple iPhone 5c (Rs 41900 for 16 GB variant) and 5s (Rs 53500 for 16GB variant) has been launched in India from 1st November.

 

The Land Acquisition Act to provide just and fair compensation to farmers will come into force from January 1 next year, said Rural Development Minister Jairam Ramesh. The Act replaces a 119 year old registration. The Securities and Exchange Board of India has approved the trading of currency futures on the Bombay Stock Exchange. The exchange plans to launch the currency futures platform with advanced trading technology by the end of November.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating : BBB-

Rating Explanation

Moderate degree of safety and moderate credit risk.

Date

August 05, 2013

 

 

Rating Agency Name

CRISIL

Rating

Short term rating : A3

Rating Explanation

Moderate degree of safety and higher credit risk.

Date

August 05, 2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered/ Corporate Office :

A-245, Ohla Industrial Area, Phase-I, New Delhi – 110020, India

Tel. No.:

91-11-45100100

Fax No.:

91-11-41708464/ 41708465

E-Mail :

sunil@bllifesciences.com

blls@bllifesciences.com

Website :

http://www.bllifesciences.com

 

 

Production Unit :

28-D, Sector-31, Ecotech-I, Greater Noida - 201306, Uttar Pradesh, India

 

 

Branch/ Representative Offices :

Located at:

 

·         Chennai

Mumbai

Bangalore

Hyderabad

Kolkata

Ahmedabad

Lucknow

Chandigarh

Jaipur

 

 

Overseas Office :

Located at:

 

·         Singapore

Dubai U.A.E

 

 

DIRECTORS

 

AS ON 30.09.2013

 

Name :

Mr. Sunil Aggarwal

Designation :

Managing director

Address :

W-57, Greater Kailash – II, New Delhi – 110048, India

Date of Birth/Age :

01.09.1965

Date of Appointment :

05.03.2008

PAN No.:

AAAPA2243D

DIN No.:

00312454

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U51909DL1984PLC017487

B L MARKETING SERVICES LIMITED

Managing director

14/04/2008

01/09/1986

-

Amalgamated

NO

2

U74899DL1995PTC071581

B.L. HOME THERAPEUTICS PRIVATE LIMITED

Director

09/08/1995

09/08/1995

-

Strike off

NO

3

U33112DL1999PTC098641

B.L.LIFE SCIENCES PRIVATE LIMITED

Managing director

05/03/2008

03/03/1999

-

Active

NO

4

U33119DL2005PTC131796

PLASTX LABS PRIVATE LIMITED

Director

03/01/2005

03/01/2005

-

Active

NO

5

U51101DL2005PTC131793

BIOLIFE MEDICAL PRIVATE LIMITED

Director

03/01/2005

03/01/2005

-

Active

NO

6

U65910DL1994PLC057109

CAPARO FINANCIAL SOLUTIONS LIMITED

Additional director

14/04/2008

14/04/2008

29/09/2008

Active

NO

7

U74899DL1995PLC068199

GEEFAM FININVEST LEASE LIMITED

Additional director

02/02/2009

02/02/2009

06/07/2009

Active

NO

8

U55101DL2013PTC249060

DRAMZ WHISKY BAR AND LOUNGE PRIVATE LIMITED

Director

05/03/2013

05/03/2013

-

Active

NO

 

 

Name :

Mr. Ajay Aggarwal

Designation :

Director

Address :

900, Dunearn Road, 01-06, Singapore 589473

Date of Birth/Age :

17.02.1964

Date of Appointment :

03.03.1999

PAN No.:

AAAPA3043R

DIN No.:

00312651

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U33112DL1999PTC098641

B.L.LIFE SCIENCES PRIVATE LIMITED

Director

03/03/1999

03/03/1999

Active

NO

2

U85110TN2003PTC051101

FRONTIER LIFELINE PRIVATE LIMITED

Director

01/10/2006

01/10/2006

Active

NO

 

 

Name :

Mr. Bhoopendra Singh Shishodia

Designation :

Whole-time director

Address :

201A, Neeti Khanda I, Indirapurama, Ghaziabad – 201001, Uttar Pradesh, India

Date of Birth/Age :

06.10.1969

Date of Appointment :

10.06.2010

PAN No.:

APSPS3566C

DIN No.:

03085915

 

 

KEY EXECUTIVES

 

Name :

Mr. Jitendra Gupta

Designation :

Secretary

Address :

221A, Kushal Nagar, Sanganer, Jaipur – 302029, Rajasthan, India

Date of Birth/Age :

22.02.1988

Date of Appointment :

01.06.2013

PAN No.:

AWLPG6416H

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2013

 

Names of Shareholders

 

No. of Shares

 

Sunil Aggarwal

 

8687134

Ajay Aggarwal

 

333000

Seema Aggarwal

 

1835000

Sejal Aggarwal

 

200200

Shubham Aggarwal

 

273266

Shakuntala Aggarwal

 

200

J.K. Aggarwal HUF

 

200

Poonam Aggarwal

 

81534

Ankur Gupta

 

200

Shubhash Gupta

 

200

Aashna Aggarwal

 

266

Abhijay Aggarwal

 

134

 

 

 

Total

 

 

11411334

 

 

AS ON 05.10.2013

 

Names of Allottees

 

No. of Shares

 

Sunil Aggarwal

 

450000

Seema Aggarwal

 

100000

 

 

 

Total

 

 

550000

 

 

AS ON 30.09.2013

 

Equity Share Breakup

Percentage of Holding

Category

 

Directors or relatives of directors

100.00

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Medical Equipments.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

·         ICICI Bank Limited, Landmarkrace Cource Circle, Alkapuri, Baroda - 390015, Gujarat, India

 

State Bank of India, SME Branch, 233, Industrial Estate Okhla, Phase-III, New Delhi - 110020, India

 

 

Facilities :

 

SECURED LOANS

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

Rupee term loans from banks

214.416

37.000

Loans and advances from related parties

3.270

144.254

Other loans and advances

0.000

0.468

SHORT TERM BORROWINGS

 

 

Term loans from banks

21.711

0.184

Working capital loans from banks

99.142

126.461

Loans and advances from related parties

0.207

0.000

Other loans and advances

0.663

7.061

 

 

 

Total

 

339.409

315.428

 

 

 

Banking Relations :

--

 

 

Auditors 1 :

 

Name :

Sam and Associates

Chartered Accountants

Address :

307, Laxmideep Building, Plot No-9, District Centre, Laxmi Nagar, Delhi-110092, India 

Tel. No.:

91-11-43044027

Mobile No.:

91-9810034027

Income-tax PAN of auditor or auditor's firm :

AACFS6838G

 

 

 

 

Auditors 2 :

 

Name :

Rajeev Mago and Associates

Chartered Accountants

Address :

G-82 (Ground Floor), Lajpat Nagar-II, New Delhi-110024, India

Tel. No.:

91-11-65633119/ 29810507

Fax No.:

91-11-29810507

Income-tax PAN of auditor or auditor's firm :

AADPM6570E

 

 

Subsidiary :

BioLife Medical Private Limited

 

 

Enterprises over which key Managerial Personnel and/ or their relative exercise significant influence :

PlastX Labs Private Limited

 

 

CAPITAL STRUCTURE

 

 

AFTER 30.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

12,000,000

Equity Shares

Rs. 10/- each

Rs. 120.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

11,961,334

Equity Shares

Rs. 10/- each

Rs. 119.613 Millions

 

 

 

 

 

 

AS ON 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

12,000,000

Equity Shares

Rs. 10/- each

Rs. 120.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

11,411,334

Equity Shares

Rs. 10/- each

Rs. 114.113 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

114.113

57.057

28.557

(b) Reserves & Surplus

170.117

192.299

162.258

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.100

Total Shareholders’ Funds (1) + (2)

284.230

249.356

190.915

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

217.686

181.722

122.141

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

217.686

181.722

122.141

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

121.723

133.706

140.057

(b) Trade payables

93.030

117.030

69.301

(c) Other current liabilities

12.861

16.063

17.724

(d) Short-term provisions

39.150

28.607

23.497

Total Current Liabilities (4)

266.764

295.406

250.579

 

 

 

 

TOTAL

768.680

726.484

563.635

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

222.001

95.705

104.489

(ii) Intangible Assets

0.084

0.109

0.000

(iii) Capital work-in-progress

0.000

122.854

59.842

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.106

0.005

0.000

(c) Deferred tax assets (net)

2.535

2.004

1.250

(d)  Long-term Loan and Advances

20.633

0.010

0.000

(e) Other Non-current assets

6.189

11.461

0.000

Total Non-Current Assets

251.548

232.148

165.581

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.005

(b) Inventories

239.643

234.892

184.544

(c) Trade receivables

204.043

195.429

158.042

(d) Cash and cash equivalents

15.044

23.604

13.716

(e) Short-term loans and advances

30.444

18.722

41.398

(f) Other current assets

27.958

21.689

0.349

Total Current Assets

517.132

494.336

398.054

 

 

 

 

TOTAL

768.680

726.484

563.635

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

TOTAL                        

865.645

786.856

734.310

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                        

801.684

735.194

675.920

 

 

 

 

 

 

PROFIT BEFORE TAX

63.961

51.662

58.390

 

 

 

 

 

Less

TAX                                                     

22.693

18.634

38.050

 

 

 

 

 

 

PROFIT AFTER TAX

41.268

33.028

20.340

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Sales

87.076

71.462

60.454

 

 

Commission Earnings

0.000

3.220

1.068

 

TOTAL EARNINGS

87.076

74.682

61.522

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

392.567

366.332

260.085

 

 

 

 

 

 

Earnings Per Share (Rs.)

3.62

5.79

7.12

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

4.77

4.20

2.77

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

8.35

8.59

11.62

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.23

0.21

0.31

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

1.19

1.26

1.37

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.94

1.67

1.59

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report

(Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10351984

14/03/2013 *

349,900,000.00

STATE BANK OF INDIA

SME BRANCH, 233, INDUSTRIAL ESTATE OKHLA, PHASE-III, NEW DELHI - 110020, INDIA

B71190383

 

* Date of charge modification

 

 

FUTURE OUTLOOK:

 

The Company shall utilize its extended manufacturing operations in Kasna, Noida, Uttar Pradesh to its fullest and keep producing a wider product range in order to grab a bigger share of market, domestic & overseas.

 

 

CONTINGENT LIABILITIES:

 

Particulars

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

(i) Guarantees given by the company to Bank towards bank guarantees to the buyers outstanding as at 31.03.2013

1.984

3.123

(ii) Foreign Letter of Credit

0.000

6.642

(iii) Estimated amount of contracts remaining to be executed on capital account not provided for

29.000

3.768

 

 

 

Total

 

30.984

13.533


FIXED ASSETS:

 

·         Buildings

Plant and equipment

Furniture and fixtures

Office equipment

Vehicles

Computer software


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 62.23

UK Pound

1

Rs. 100.18

Euro

1

Rs. 84.06

 

 

INFORMATION DETAILS

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS 

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

47

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.